Drugs / RO 205-2349
last change Mar 2004 re-read 3 minutes ago

RO 205-2349

Developed for
diabetes mellitus · type 2 diabetes mellitus
Investigated by
Hoffmann-La Roche

Trials 2

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00057304 Jun 2003 → Mar 2004 diabetes mellitus Hoffmann-La Roche Completed No outcome recorded
Phase 2 NCT00057317 Dec 2001 → Dec 2003 type 2 diabetes mellitus Hoffmann-La Roche Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as RO 205-2349 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00057304 ↗
1

NCT00057317 ↗